Renaissance Technologies’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,820
| Closed | -$8K | – | 4430 |
|
|
2023
Q1 | $8K | Sell |
13,820
-500
| -3% | -$398 | ﹤0.01% | 3900 |
|
|
2022
Q4 | $10K | Buy |
14,320
+10,160
| +244% | +$16.5K | ﹤0.01% | 4039 |
|
|
2022
Q3 | $12K | Buy |
4,160
+100
| +2% | +$378 | ﹤0.01% | 3942 |
|
|
2022
Q2 | $18K | Buy |
4,060
+178
| +5% | +$781 | ﹤0.01% | 4132 |
|
|
2022
Q1 | $28K | Sell |
3,882
-15,386
| -80% | -$89.4K | ﹤0.01% | 3979 |
|
|
2021
Q4 | $130K | Sell |
19,268
-2,572
| -12% | -$26.3K | ﹤0.01% | 3636 |
|
|
2021
Q3 | $254K | Buy |
+21,840
| New | +$302K | ﹤0.01% | 3131 |
|
|
2021
Q2 | – | Sell |
-36,185
| Closed | -$839K | – | 3886 |
|
|
2021
Q1 | $839K | Sell |
36,185
-12,375
| -25% | -$313K | ﹤0.01% | 2681 |
|
|
2020
Q4 | $673K | Buy |
48,560
+9,880
| +26% | +$146K | ﹤0.01% | 2691 |
|
|
2020
Q3 | $803K | Buy |
38,680
+3,980
| +11% | +$74.9K | ﹤0.01% | 2623 |
|
|
2020
Q2 | $526K | Buy |
34,700
+2,512
| +8% | +$39.2K | ﹤0.01% | 2856 |
|
|
2020
Q1 | $443K | Sell |
32,188
-1,418
| -4% | -$28.8K | ﹤0.01% | 2820 |
|
|
2019
Q4 | $1M | Buy |
33,606
+8,304
| +33% | +$199K | ﹤0.01% | 2629 |
|
|
2019
Q3 | $391K | Buy |
25,302
+6,788
| +37% | +$132K | ﹤0.01% | 2949 |
|
|
2019
Q2 | $453K | Buy |
18,514
+5,132
| +38% | +$160K | ﹤0.01% | 3031 |
|
|
2019
Q1 | $482K | Buy |
13,382
+7,324
| +121% | +$301K | ﹤0.01% | 2935 |
|
|
2018
Q4 | $220K | Buy |
6,058
+1,557
| +35% | +$131K | ﹤0.01% | 3109 |
|
|
2018
Q3 | $702K | Buy |
4,501
+586
| +15% | +$86.7K | ﹤0.01% | 2746 |
|
|
2018
Q2 | $523K | Buy |
3,915
+706
| +22% | +$107K | ﹤0.01% | 2819 |
|
|
2018
Q1 | $794K | Sell |
3,209
-256
| -7% | -$72.1K | ﹤0.01% | 2746 |
|
|
2017
Q4 | $962K | Sell |
3,465
-331
| -9% | -$126K | ﹤0.01% | 2672 |
|
|
2017
Q3 | $1.54M | Sell |
3,796
-2
| -0.1% | -$1.04K | ﹤0.01% | 2406 |
|
|
2017
Q2 | $2.25M | Buy |
3,798
+801
| +27% | +$468K | ﹤0.01% | 2200 |
|
|
2017
Q1 | $1.84M | Buy |
2,997
+928
| +45% | +$330K | ﹤0.01% | 2283 |
|
|
2016
Q4 | $419K | Buy |
2,069
+891
| +76% | +$203K | ﹤0.01% | 2819 |
|
|
2016
Q3 | $309K | Buy |
1,178
+503
| +75% | +$154K | ﹤0.01% | 2951 |
|
|
2016
Q2 | $201K | Buy |
675
+195
| +41% | +$68.6K | ﹤0.01% | 3048 |
|
|
2016
Q1 | $204K | Sell |
480
-573
| -54% | -$214K | ﹤0.01% | 3081 |
|
|
2015
Q4 | $521K | Buy |
1,053
+506
| +93% | +$366K | ﹤0.01% | 2720 |
|
|
2015
Q3 | $642K | Buy |
547
+88
| +19% | +$135K | ﹤0.01% | 2549 |
|
|
2015
Q2 | $810K | Buy |
459
+385
| +520% | +$599K | ﹤0.01% | 2550 |
|
|
2015
Q1 | $87K | Buy |
74
+5
| +7% | +$5.92K | ﹤0.01% | 3028 |
|
|
2014
Q4 | $69K | Buy |
+69
| New | +$69.1K | ﹤0.01% | 2850 |
|
Other funds holding VYNT
Renaissance Technologies's VYNT Position: Q2 2023 in Review
Renaissance Technologies sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 13,820 shares — an estimated $8K sold.
Renaissance Technologies first reported a position in VYNT in Q4 2014 and held it in 33 quarters. The position peaked at $2.25M in Q2 2017. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.
- Renaissance Technologies reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Renaissance Technologies sold 13,820 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $8K.
- Renaissance Technologies first reported a position in Vyant Bio, Inc. Common Stock in Q4 2014 and held it in 33 quarters.
- Renaissance Technologies's Vyant Bio, Inc. Common Stock position peaked at $2.25M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.